Animal models for the preclinical evaluation of candidate influenza vaccines

References

• Webster RG, Bean WJ, Gorman OT, Chambers TM, Kawaoka Y. Evolution and ecology of influenza A viruses. Microbiol. Rev.56(1), 152–179 (1992).
   PubMedGoogle Scholar
• Reperant LA, Rimmelzwaan GF, Kuiken T. Avian influenza viruses in mammals. Rev. Sci. Tech.28(1), 137–159 (2009).
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). Update: infections with a swine-origin influenza A (H1N1) virus – United States and other countries, April 28, 2009. MMWR Morb. Mortal. Wkly Rep.58(16), 431–433 (2009).
   PubMedGoogle Scholar
• Garten RJ, Davis CT, Russell CA et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science325(5937), 197–201 (2009).
   PubMed Web of Science ®Google Scholar
• Zhang H, Chen L. Possible origin of current influenza A H1N1 viruses. Lancet Infect. Dis.9(8), 456–457 (2009).
   PubMed Web of Science ®Google Scholar
• de Jong JC, Claas EC, Osterhaus AD, Webster RG, Lim WL. A pandemic warning? Nature389(6651), 554 (1997).
   PubMed Web of Science ®Google Scholar
• Subbarao K, Klimov A, Katz J et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science279(5349), 393–396 (1998).
   PubMed Web of Science ®Google Scholar
• Yang Y, Halloran ME, Sugimoto JD, Longini IM Jr. Detecting human-to-human transmission of avian influenza A (H5N1). Emerg. Infect. Dis.13(9), 1348–1353 (2007).
   PubMed Web of Science ®Google Scholar
• Ungchusak K, Auewarakul P, Dowell SF et al. Probable person-to-person transmission of avian influenza A (H5N1). N. Engl. J. Med.352(4), 333–340 (2005).
   PubMed Web of Science ®Google Scholar
• Lin YP, Shaw M, Gregory V et al. Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proc. Natl Acad. Sci. USA97(17), 9654–9658 (2000).
   PubMed Web of Science ®Google Scholar
• Fouchier RA, Schneeberger PM, Rozendaal FW et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc. Natl Acad. Sci. USA101(5), 1356–1361 (2004).
   PubMed Web of Science ®Google Scholar
• Olsen B, Munster VJ, Wallensten A et al. Global patterns of influenza a virus in wild birds. Science312(5772), 384–388 (2006).
   PubMed Web of Science ®Google Scholar
• Crawford PC, Dubovi EJ, Castleman WL et al. Transmission of equine influenza virus to dogs. Science310(5747), 482–485 (2005).
   PubMed Web of Science ®Google Scholar
• Cardona CJ, Xing Z, Sandrock CE, Davis CE. Avian influenza in birds and mammals. Comp. Immunol. Microbiol. Infect. Dis.32(4), 255–273 (2009).
   PubMed Web of Science ®Google Scholar
• Thiry E, Zicola A, Addie D et al. Highly pathogenic avian influenza H5N1 virus in cats and other carnivores. Vet. Microbiol.122(1–2), 25–31 (2007).
   PubMed Web of Science ®Google Scholar
• Baigent SJ, McCauley JW. Influenza type A in humans, mammals and birds: determinants of virus virulence, host-range and interspecies transmission. Bioessays25(7), 657–671 (2003).
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Ito T, Suzuki T et al. Sialic acid species as a determinant of the host range of influenza A viruses. J. Virol.74(24), 11825–11831 (2000).
   PubMed Web of Science ®Google Scholar
• van Riel D, Munster VJ, de Wit E et al. Human and avian influenza viruses target different cells in the lower respiratory tract of humans and other mammals. Am. J. Pathol.171(4), 1215–1223 (2007).
   PubMed Web of Science ®Google Scholar
• van Riel D, Munster VJ, de Wit E et al. H5N1 virus attachment to lower respiratory tract. Science312(5772), 399 (2006).
   PubMed Web of Science ®Google Scholar
• Baskin CR, Bielefeldt-Ohmann H, Tumpey TM et al. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc. Natl Acad. Sci. USA106(9), 3455–3460 (2009).
   PubMed Web of Science ®Google Scholar
• de Jong MD, Simmons CP, Thanh TT et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat. Med.12(10), 1203–1207 (2006).
   PubMed Web of Science ®Google Scholar
• Seo SH, Hoffmann E, Webster RG. The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses. Virus Res.103(1–2), 107–113 (2004).
   PubMed Web of Science ®Google Scholar
• de Wit E, Kawaoka Y, de Jong MD, Fouchier RA. Pathogenicity of highly pathogenic avian influenza virus in mammals. Vaccine26(Suppl. 4), D54–D58 (2008).
   PubMed Web of Science ®Google Scholar
• Seo SH, Hoffmann E, Webster RG. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat. Med.8(9), 950–954 (2002).
   PubMed Web of Science ®Google Scholar
• Gambotto A, Barratt-Boyes SM, de Jong MD, Neumann G, Kawaoka Y. Human infection with highly pathogenic H5N1 influenza virus. Lancet371(9622), 1464–1475 (2008).
   PubMed Web of Science ®Google Scholar
• Korteweg C, Gu J. Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am. J. Pathol.172(5), 1155–1170 (2008).
   PubMed Web of Science ®Google Scholar
• Staeheli P, Grob R, Meier E, Sutcliffe JG, Haller O. Influenza virus-susceptible mice carry Mx genes with a large deletion or a nonsense mutation. Mol. Cell. Biol.8(10), 4518–4523 (1988).
   PubMed Web of Science ®Google Scholar
• Pavlovic J, Haller O, Staeheli P. Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle. J. Virol.66(4), 2564–2569 (1992).
   PubMed Web of Science ®Google Scholar
• Narasaraju T, Sim MK, Ng HH et al. Adaptation of human influenza H3N2 virus in a mouse pneumonitis model: insights into viral virulence, tissue tropism and host pathogenesis. Microbes Infect.11(1), 2–11 (2009).
   PubMed Web of Science ®Google Scholar
• Wu R, Zhang H, Yang K et al. Multiple amino acid substitutions are involved in the adaptation of H9N2 avian influenza virus to mice. Vet. Microbiol.138(1–2), 85–91 (2009).
   PubMed Web of Science ®Google Scholar
• Subbarao K, Luke C. H5N1 viruses and vaccines. PLoS Pathog.3(3), e40 (2007).
   PubMed Web of Science ®Google Scholar
• de Wit E, Munster VJ, Spronken MI et al. Protection of mice against lethal infection with highly pathogenic H7N7 influenza A virus by using a recombinant low-pathogenicity vaccine strain. J. Virol.79(19), 12401–12407 (2005).
   PubMedGoogle Scholar
• Lu X, Tumpey TM, Morken T et al. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J. Virol.73(7), 5903–5911 (1999).
   PubMed Web of Science ®Google Scholar
• Maines TR, Jayaraman A, Belser JA et al. Transmission and pathogenesis of swine-origin 2009 A(H1N1) influenza viruses in ferrets and mice. Science325(5939), 484–487 (2009).
   PubMed Web of Science ®Google Scholar
• Itoh Y, Shinya K, Kiso M et al.In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature460(7258), 1021–1025 (2009).
   PubMed Web of Science ®Google Scholar
• Boon AC, deBeauchamp J, Hollmann A et al. Host genetic variation affects resistance to infection with a highly pathogenic H5N1 influenza A virus in mice. J. Virol.83(20), 10417–10426 (2009).
   PubMedGoogle Scholar
• Trammell RA, Toth LA. Genetic susceptibility and resistance to influenza infection and disease in humans and mice. Expert Rev. Mol. Diagn.8(4), 515–529 (2008).
   PubMed Web of Science ®Google Scholar
• Kreijtz JH, Suezer Y, van Amerongen G et al. Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1. J. Infect. Dis.195(11), 1598–1606 (2007).
   PubMed Web of Science ®Google Scholar
• Gao P, Watanabe S, Ito T et al. Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong. J. Virol.73(4), 3184–3189 (1999).
   PubMed Web of Science ®Google Scholar
• Toth LA, Verhulst SJ. Strain differences in sleep patterns of healthy and influenza-infected inbred mice. Behav. Genet.33(3), 325–336 (2003).
   PubMedGoogle Scholar
• Ding M, Lu L, Toth LA. Gene expression in lung and basal forebrain during influenza infection in mice. Genes Brain Behav.7(2), 173–183 (2008).
   PubMedGoogle Scholar
• Ottolini MG, Blanco JC, Eichelberger MC et al. The cotton rat provides a useful small-animal model for the study of influenza virus pathogenesis. J. Gen. Virol.86(Pt 10), 2823–2830 (2005).
   PubMed Web of Science ®Google Scholar
• Boukhvalova MS, Prince GA, Blanco JC. The cotton rat model of respiratory viral infections. Biologicals37(3), 152–159 (2009).
   PubMed Web of Science ®Google Scholar
• Azoulay-Dupuis E, Lambre CR, Soler P, Moreau J, Thibon M. Lung alterations in guinea-pigs infected with influenza virus. J. Comp. Pathol.94(2), 273–283 (1984).
   PubMedGoogle Scholar
• Phair JP, Kauffman CA, Jennings R, Potter CW. Influenza virus infection of the guinea pig: immune response and resistance. Med. Microbiol. Immunol.165(4), 241–254 (1979).
   PubMed Web of Science ®Google Scholar
• Wetherbee RE. Induction of systemic delayed hypersensitivity during experimental viral infection of the respiratory tract with a myxovirus or paramyxovirus. J. Immunol.111(1), 157–163 (1973).
   PubMedGoogle Scholar
• Lowen AC, Mubareka S, Tumpey TM, Garcia-Sastre A, Palese P. The guinea pig as a transmission model for human influenza viruses. Proc. Natl Acad. Sci. USA103(26), 9988–9992 (2006).
   PubMed Web of Science ®Google Scholar
• Van Hoeven N, Belser JA, Szretter KJ et al. Pathogenesis of 1918 pandemic and H5N1 influenza virus infections in a guinea pig model: antiviral potential of exogenous α interferon to reduce virus shedding. J. Virol.83(7), 2851–2861 (2009).
   PubMed Web of Science ®Google Scholar
• Kwon YK, Lipatov AS, Swayne DE. Bronchointerstitial pneumonia in guinea pigs following inoculation with H5N1 high pathogenicity avian influenza virus. Vet. Pathol.46(1), 138–141 (2009).
   PubMed Web of Science ®Google Scholar
• Steel J, Lowen AC, Mubareka S, Palese P. Transmission of influenza virus in a mammalian host is increased by PB2 amino acids 627K or 627E/701N. PLoS Pathog.5(1), e1000252 (2009).
   PubMed Web of Science ®Google Scholar
• Tang X, Chong KT. Histopathology and growth kinetics of influenza viruses (H1N1 and H3N2) in the upper and lower airways of guinea pigs. J. Gen. Virol.90(Pt 2), 386–391 (2009).
   PubMedGoogle Scholar
• Lange E, Kalthoff D, Blohm U et al. Pathogenesis and transmission of the novel swine-origin influenza virus A/H1N1 after experimental infection of pigs. J. Gen. Virol.90(Pt 9), 2119–2123 (2009).
   PubMedGoogle Scholar
• Van Reeth K. Avian and swine influenza viruses: our current understanding of the zoonotic risk. Vet. Res.38(2), 243–260 (2007).
   PubMed Web of Science ®Google Scholar
• Lipatov AS, Kwon YK, Sarmento LV et al. Domestic pigs have low susceptibility to H5N1 highly pathogenic avian influenza viruses. PLoS Pathog.4(7), e1000102 (2008).
   PubMed Web of Science ®Google Scholar
• Kuiken T, Rimmelzwaan G, van Riel D et al. Avian H5N1 influenza in cats. Science306(5694), 241 (2004).
   PubMed Web of Science ®Google Scholar
• Rimmelzwaan GF, van Riel D, Baars M et al. Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. Am. J. Pathol.168(1), 176–183 (2006).
   PubMed Web of Science ®Google Scholar
• Leschnik M, Weikel J, Mostl K et al. Subclinical infection with avian influenza A (H5N1) virus in cats. Emerg. Infect. Dis.13(2), 243–247 (2007).
   PubMedGoogle Scholar
• Smith W, Andrewes CH, Laidlaw PP. A virus obtained from influenza patients. Lancetii, 66–68 (1933).
   Google Scholar
• Reuman PD, Keely S, Schiff GM. Assessment of signs of influenza illness in the ferret model. J. Virol. Methods24(1–2), 27–34 (1989).
   PubMed Web of Science ®Google Scholar
• Munster VJ, de Wit E, van den Brand JM et al. Pathogenesis and transmission of swine-origin 2009 A (H1N1) influenza virus in ferrets. Science325(5939), 481–483 (2009).
   PubMed Web of Science ®Google Scholar
• Andrewes CH, Glover RE. Spread of infection from the respiratory tract of the ferret. Transmission of influenza A virus. Br. J. Exp. Pathol.16, 291–302 (1941).
   Google Scholar
• Herlocher ML, Elias S, Truscon R et al. Ferrets as a transmission model for influenza: sequence changes in HA1 of type A (H3N2) virus. J. Infect. Dis.184(5), 542–546 (2001).
   PubMedGoogle Scholar
• Maines TR, Chen LM, Matsuoka Y et al. Lack of transmission of H5N1 avian-human reassortant influenza viruses in a ferret model. Proc. Natl Acad. Sci. USA103(32), 12121–12126 (2006).
   PubMed Web of Science ®Google Scholar
• Govorkova EA, Rehg JE, Krauss S et al. Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J. Virol.79(4), 2191–2198 (2005).
   PubMed Web of Science ®Google Scholar
• Zitzow LA, Rowe T, Morken T et al. Pathogenesis of avian influenza A (H5N1) viruses in ferrets. J. Virol.76(9), 4420–4429 (2002).
   PubMed Web of Science ®Google Scholar
• Boltz DA, Rehg JE, McClaren J, Webster RG, Govorkova EA. Oseltamivir prophylactic regimens prevent H5N1 influenza morbidity and mortality in a ferret model. J. Infect. Dis.197(9), 1315–1323 (2008).
   PubMed Web of Science ®Google Scholar
• Baras B, Stittelaar KJ, Simon JH et al. Cross-protection against lethal H5N1 challenge in ferrets with an adjuvanted pandemic influenza vaccine. PLoS ONE3(1), e1401 (2008).
   PubMed Web of Science ®Google Scholar
• Mahmood K, Bright RA, Mytle N et al. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses. Vaccine26(42), 5393–5399 (2008).
   PubMed Web of Science ®Google Scholar
• Peltola VT, Boyd KL, McAuley JL, Rehg JE, McCullers JA. Bacterial sinusitis and otitis media following influenza virus infection in ferrets. Infect. Immun.74(5), 2562–2567 (2006).
   PubMed Web of Science ®Google Scholar
• Rimmelzwaan GF, Baars M, van Beek R et al. Induction of protective immunity against influenza virus in a macaque model: comparison of conventional and iscom vaccines. J. Gen. Virol.78( Pt 4), 757–765 (1997).
   PubMed Web of Science ®Google Scholar
• Baas T, Baskin CR, Diamond DL et al. Integrated molecular signature of disease: analysis of influenza virus-infected macaques through functional genomics and proteomics. J. Virol.80(21), 10813–10828 (2006).
   PubMed Web of Science ®Google Scholar
• Villinger F, Miller R, Mori K et al. IL-15 is superior to IL-2 in the generation of long-lived antigen specific memory CD4 and CD8 T cells in rhesus macaques. Vaccine22(25–26), 3510–3521 (2004).
   PubMed Web of Science ®Google Scholar
• Baskin CR, Garcia-Sastre A, Tumpey TM et al. Integration of clinical data, pathology, and cDNA microarrays in influenza virus-infected pigtailed macaques (Macaca nemestrina). J. Virol.78(19), 10420–10432 (2004).
   PubMed Web of Science ®Google Scholar
• Rimmelzwaan GF, Kuiken T, van Amerongen G et al. Pathogenesis of influenza A (H5N1) virus infection in a primate model. J. Virol.75(14), 6687–6691 (2001).
   PubMed Web of Science ®Google Scholar
• Kuiken T, Rimmelzwaan GF, Van Amerongen G, Osterhaus AD. Pathology of human influenza A (H5N1) virus infection in cynomolgus macaques (Macaca fascicularis). Vet. Pathol.40(3), 304–310 (2003).
   PubMed Web of Science ®Google Scholar
• Kobasa D, Jones SM, Shinya K et al. Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature445(7125), 319–323 (2007).
   PubMed Web of Science ®Google Scholar
• Berendt RF. Simian model for the evaluation of immunity to influenza. Infect. Immun.9(1), 101–105 (1974).
   PubMed Web of Science ®Google Scholar
• Kreijtz JH, Suezer Y, de Mutsert G et al. Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques. J. Infect. Dis.199(3), 405–413 (2009).
   PubMed Web of Science ®Google Scholar
• Itoh Y, Ozaki H, Tsuchiya H et al. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques. Vaccine26(4), 562–572 (2008).
   PubMedGoogle Scholar
• Lowen AC, Steel J, Mubareka S et al. Blocking interhost transmission of influenza virus by vaccination in the guinea pig model. J. Virol.83(7), 2803–2818 (2009).
   PubMed Web of Science ®Google Scholar
• Lowen AC, Palese P. Influenza virus transmission: basic science and implications for the use of antiviral drugs during a pandemic. Infect. Disord. Drug Targets7(4), 318–328 (2007).
   PubMedGoogle Scholar
• Suguitan AL Jr, McAuliffe J, Mills KL et al. Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets. PLoS Med.3(9), e360 (2006).
   PubMed Web of Science ®Google Scholar
• Jegerlehner A, Schmitz N, Storni T, Bachmann MF. Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J. Immunol.172(9), 5598–5605 (2004).
   PubMed Web of Science ®Google Scholar
• Geeraedts F, Goutagny N, Hornung V et al. Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling. PLoS Pathog.4(8), e1000138 (2008).
   PubMed Web of Science ®Google Scholar
• Dupuis M, Denis-Mize K, LaBarbara A et al. Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosis. Eur. J. Immunol.31(10), 2910–2918 (2001).
   PubMed Web of Science ®Google Scholar
• Hu N, D’Souza C, Cheung H et al. Highly conserved pattern of recognition of influenza A wild-type and variant CD8+ CTL epitopes in HLA-A2+ humans and transgenic HLA-A2+/H2 class I-deficient mice. Vaccine23(45), 5231–5244 (2005).
   PubMedGoogle Scholar
• Yu CI, Gallegos M, Marches F et al. Broad influenza-specific CD8+ T-cell responses in humanized mice vaccinated with influenza virus vaccines. Blood112(9), 3671–3678 (2008).
   PubMed Web of Science ®Google Scholar
• Cameron CM, Cameron MJ, Bermejo-Martin JF et al. Gene expression analysis of host innate immune responses during lethal H5N1 infection in ferrets. J. Virol.82(22), 11308–11317 (2008).
   PubMed Web of Science ®Google Scholar
• Ochi A, Danesh A, Seneviratne C et al. Cloning, expression and immunoassay detection of ferret IFN-γ. Dev. Comp. Immunol.32(8), 890–897 (2008).
   PubMedGoogle Scholar
• Nakata M, Itou T, Sakai T. Molecular cloning and phylogenetic analysis of inflammatory cytokines of the ferret (Mustela putorius furo). J. Vet. Med. Sci.70(6), 543–550 (2008).
   PubMed Web of Science ®Google Scholar
• Svitek N, Rudd PA, Obojes K, Pillet S, von Messling V. Severe seasonal influenza in ferrets correlates with reduced interferon and increased IL-6 induction. Virology376(1), 53–59 (2008).
   PubMed Web of Science ®Google Scholar
• Ljungberg K, Kolmskog C, Wahren B et al. DNA vaccination of ferrets with chimeric influenza A virus hemagglutinin (H3) genes. Vaccine20(16), 2045–2052 (2002).
   PubMedGoogle Scholar
• Leroux-Roels I, Borkowski A, Vanwolleghem T et al. Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial. Lancet370(9587), 580–589 (2007).
   PubMed Web of Science ®Google Scholar
• Middleton D, Rockman S, Pearse M et al. Evaluation of vaccines for H5N1 influenza virus in ferrets reveals the potential for protective single-shot immunization. J. Virol.83(15), 7770–7778 (2009).
   PubMed Web of Science ®Google Scholar
• Govorkova EA, Webby RJ, Humberd J, Seiler JP, Webster RG. Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge. J. Infect. Dis.194(2), 159–167 (2006).
   PubMed Web of Science ®Google Scholar
• Lipatov AS, Hoffmann E, Salomon R, Yen HL, Webster RG. Cross-protectiveness and immunogenicity of influenza A/Duck/Singapore/3/97(H5) vaccines against infection with A/Vietnam/1203/04(H5N1) virus in ferrets. J. Infect. Dis.194(8), 1040–1043 (2006).
   PubMedGoogle Scholar
• Lalor PA, Webby RJ, Morrow J et al. Plasmid DNA-based vaccines protect mice and ferrets against lethal challenge with A/Vietnam/1203/04 (H5N1) influenza virus. J. Infect. Dis.197(12), 1643–1652 (2008).
   PubMed Web of Science ®Google Scholar
• Li S, Liu C, Klimov A et al. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses. J. Infect. Dis.179(5), 1132–1138 (1999).
   PubMed Web of Science ®Google Scholar
• Bell FR, Dudgeon JA. An epizootic in influenza in a ferret colony. J. Comp. Pathol. Ther.58(3), 167–171 (1948).
   PubMedGoogle Scholar
• Stittelaar KJ, de Swart RL, Osterhaus AD. Vaccination against measles: a neverending story. Expert Rev. Vaccines1(2), 151–159 (2002).
   PubMedGoogle Scholar
• Ruat C, Caillet C, Bidaut A, Simon J, Osterhaus AD. Vaccination of macaques with adjuvanted formalin-inactivated influenza A virus (H5N1) vaccines: protection against H5N1 challenge without disease enhancement. J. Virol.82(5), 2565–2569 (2008).
   PubMed Web of Science ®Google Scholar
• Fan S, Gao Y, Shinya K et al. Immunogenicity and protective efficacy of a live attenuated H5N1 vaccine in nonhuman primates. PLoS Pathog.5(5), e1000409 (2009).
   PubMed Web of Science ®Google Scholar
• DiNapoli JM, Yang L, Suguitan A Jr. et al. Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus. J. Virol.81(21), 11560–11568 (2007).
   PubMed Web of Science ®Google Scholar
• Rimmelzwaan GF, Baars M, van Beek R et al. Influenza virus subtype cross-reactivities of haemagglutination inhibiting and virus neutralising serum antibodies induced by infection or vaccination with an ISCOM-based vaccine. Vaccine17(20–21), 2512–2516 (1999).
   PubMed Web of Science ®Google Scholar
• Rimmelzwaan GF, Baars M, van Amerongen G, van Beek R, Osterhaus AD. A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect cynomolgus macaques against distant drift variants of influenza A (H3N2) viruses. Vaccine20(1–2), 158–163 (2001).
   PubMed Web of Science ®Google Scholar
• Van Reeth K, Labarque G, De Clercq S, Pensaert M. Efficacy of vaccination of pigs with different H1N1 swine influenza viruses using a recent challenge strain and different parameters of protection. Vaccine19(31), 4479–4486 (2001).
   PubMed Web of Science ®Google Scholar
• Van Reeth K, Van Gucht S, Pensaert M. Correlations between lung proinflammatory cytokine levels, virus replication, and disease after swine influenza virus challenge of vaccination-immune pigs. Viral Immunol.15(4), 583–594 (2002).
   PubMed Web of Science ®Google Scholar
• Richt JA, Lekcharoensuk P, Lager KM et al. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine. J. Virol.80(22), 11009–11018 (2006).
   PubMedGoogle Scholar
• Wesley RD, Tang M, Lager KM. Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus. Vaccine22(25–26), 3427–3434 (2004).
   PubMed Web of Science ®Google Scholar
• Heinen PP, Rijsewijk FA, de Boer-Luijtze EA, Bianchi AT. Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus. J. Gen. Virol.83(Pt 8), 1851–1859 (2002).
   PubMed Web of Science ®Google Scholar
• Swayne DE, Suarez DL. Current developments in avian influenza vaccines, including safety of vaccinated birds as food. Dev. Biol. (Basel)130, 123–133 (2007).
   PubMedGoogle Scholar
• Swayne DE. Avian influenza vaccines and therapies for poultry. Comp. Immunol. Microbiol. Infect. Dis.32(4), 351–363 (2009).
   PubMed Web of Science ®Google Scholar
• Paillot R, Hannant D, Kydd JH, Daly JM. Vaccination against equine influenza: quid novi? Vaccine24(19), 4047–4061 (2006).
   PubMedGoogle Scholar
• Ulmer JB, Donnelly JJ, Parker SE et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science259(5102), 1745–1749 (1993).
   PubMed Web of Science ®Google Scholar
• Fynan EF, Webster RG, Fuller DH et al. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc. Natl Acad. Sci. USA90(24), 11478–11482 (1993).
   PubMed Web of Science ®Google Scholar
• Lu S, Wang S, Grimes-Serrano JM. Current progress of DNA vaccine studies in humans. Expert Rev. Vaccines7(2), 175–191 (2008).
   PubMed Web of Science ®Google Scholar
• Drape RJ, Macklin MD, Barr LJ et al. Epidermal DNA vaccine for influenza is immunogenic in humans. Vaccine24(21), 4475–4481 (2006).
   PubMed Web of Science ®Google Scholar
• Fiers W, De Filette M, El Bakkouri K et al. M2e-based universal influenza A vaccine. Vaccine27(45), 6280–6283 (2009).
   PubMed Web of Science ®Google Scholar
• O’Hagan DT. MF59 is a safe and potent vaccine adjuvant that enhances protection against influenza virus infection. Expert Rev. Vaccines6(5), 699–710 (2007).
   PubMed Web of Science ®Google Scholar
• Stephenson I, Nicholson KG, Hoschler K et al. Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1. N. Engl. J. Med.359(15), 1631–1633 (2008).
   PubMed Web of Science ®Google Scholar
• O’Hagan DT, Wack A, Podda A. MF59 is a safe and potent vaccine adjuvant for flu vaccines in humans: what did we learn during its development? Clin. Pharmacol. Ther.82(6), 740–744 (2007).
   PubMed Web of Science ®Google Scholar
• Hoelscher MA, Singh N, Garg S et al. A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses. J. Infect. Dis.197(8), 1185–1188 (2008).
   PubMed Web of Science ®Google Scholar
• Van Kampen KR, Shi Z, Gao P et al. Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans. Vaccine23(8), 1029–1036 (2005).
   PubMed Web of Science ®Google Scholar
• Gao W, Soloff AC, Lu X et al. Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J. Virol.80(4), 1959–1964 (2006).
   PubMed Web of Science ®Google Scholar
• Rowe T, Abernathy RA, Hu-Primmer J et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J. Clin. Microbiol.37(4), 937–943 (1999).
   PubMed Web of Science ®Google Scholar
• Cassetti MC, Katz JM, Wood J. Report of a consultation on role of immunological assays to evaluate efficacy of influenza vaccines. Initiative for Vaccine Research and Global Influenza Programme, World Health Organization, Geneva, Switzerland, 25 January 2005. Vaccine24(5), 541–543 (2006).
   PubMedGoogle Scholar
• Cassetti MC, Couch R, Wood J, Pervikov Y. Report of meeting on the development of influenza vaccines with broad spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 26–27 February 2004. Vaccine23(13), 1529–1533 (2005).
   PubMedGoogle Scholar
• Altman JD, Moss PA, Goulder PJ et al. Phenotypic analysis of antigen-specific T lymphocytes. Science274(5284), 94–96 (1996).
   PubMed Web of Science ®Google Scholar
• Belz GT, Xie W, Altman JD, Doherty PC. A previously unrecognized H-2D(b)-restricted peptide prominent in the primary influenza A virus-specific CD8+ T-cell response is much less apparent following secondary challenge. J. Virol.74(8), 3486–3493 (2000).
   PubMed Web of Science ®Google Scholar
• Fornek JL, Korth MJ, Katze MG. Use of functional genomics to understand influenza–host interactions. Adv. Virus Res.70, 81–100 (2007).
   PubMedGoogle Scholar
• Perkins LE, Swayne DE. Comparative susceptibility of selected avian and mammalian species to a Hong Kong-origin H5N1 high-pathogenicity avian influenza virus. Avian Dis.47(3 Suppl.), 956–967 (2003).
   PubMed Web of Science ®Google Scholar
• Maas R, Tacken M, Ruuls L et al. Avian influenza (H5N1) susceptibility and receptors in dogs. Emerg. Infect. Dis.13(8), 1219–1221 (2007).
   PubMed Web of Science ®Google Scholar
• Choi YK, Nguyen TD, Ozaki H et al. Studies of H5N1 influenza virus infection of pigs by using viruses isolated in Vietnam and Thailand in 2004. J. Virol.79(16), 10821–10825 (2005).
   PubMed Web of Science ®Google Scholar
• Isoda N, Sakoda Y, Kishida N et al. Pathogenicity of a highly pathogenic avian influenza virus, A/chicken/Yamaguchi/7/04 (H5N1) in different species of birds and mammals. Arch. Virol.151(7), 1267–1279 (2006).
   PubMed Web of Science ®Google Scholar
• Reperant LA, van Amerongen G, van de Bildt MW et al. Highly pathogenic avian influenza virus (H5N1) infection in red foxes fed infected bird carcasses. Emerg. Infect. Dis.14(12), 1835–1841 (2008).
   PubMed Web of Science ®Google Scholar
• Kalthoff D, Hoffmann B, Harder T, Durban M, Beer M. Experimental infection of cattle with highly pathogenic avian influenza virus (H5N1). Emerg. Infect. Dis.14(7), 1132–1134 (2008).
   PubMedGoogle Scholar
• Smith H, Sweet C. Lessons for human influenza from pathogenicity studies with ferrets. Rev. Infect. Dis.10(1), 56–75 (1988).
   PubMedGoogle Scholar